Gerben J. van der Bij

Macrophages direct tumour histology and clinical outcome in a colon cancer model

Steven J. Oosterling, Gerben J. van der Bij, Gerrit A. Meijer et al. · The Journal of Pathology · 2005 · 126 citations · Full text

Tumour Histology, Tumour Stroma, Immunology +20

Experimental Antibody Therapy of Liver Metastases Reveals Functional Redundancy between FcγRI and FcγRIV

Marielle A. Otten, Gerben J. van der Bij, Sjef Verbeek et al. · The Journal of Immunology · 2008 · 82 citations · Full text

Immunology, Pathology, Immune System +18

Insufficient ability of omental milky spots to prevent peritoneal tumor outgrowth supports omentectomy in minimal residual disease

Steven J. Oosterling, Gerben J. van der Bij, Marijn Bögels et al. · Cancer Immunology Immunotherapy · 2005 · 76 citations · Full text

Surgical Oncology, Tumoral Pathology, Insufficient Ability +7

Prolonged Maturation and Enhanced Transduction of Dendritic Cells Migrated from Human Skin Explants After In Situ Delivery of CD40-Targeted Adenoviral Vectors

Tanja D. de Gruijl, Sylvia A. Luykx‐de Bakker, Bryan Tillman et al. · The Journal of Immunology · 2002 · 65 citations · Full text

Experimentally induced liver metastases from colorectal cancer can be prevented by mononuclear phagocyte-mediated monoclonal antibody therapy

Gerben J. van der Bij, Marijn Bögels, Marielle A. Otten et al. · Journal of Hepatology · 2010 · 57 citations

Medicine, Hepatobiliary Tumor, Immunology +9